SPATA25
gene geneOn this page
Also known as dJ337O18.8TSG23
Summary
SPATA25 (spermatogenesis associated 25, HGNC:16158) is a protein-coding gene on chromosome 20q13.12, encoding Spermatogenesis-associated protein 25 (Q9BR10). May play a role in spermatogenesis.
Involved in spermatogenesis. Predicted to be located in membrane.
Source: NCBI Gene 128497 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 34 total
- MANE Select transcript:
NM_080608
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16158 |
| Approved symbol | SPATA25 |
| Name | spermatogenesis associated 25 |
| Location | 20q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ337O18.8, TSG23 |
| Ensembl gene | ENSG00000149634 |
| Ensembl biotype | protein_coding |
| OMIM | 618936 |
| Entrez | 128497 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000372519
RefSeq mRNA: 1 — MANE Select: NM_080608
NM_080608
CCDS: CCDS13383
Canonical transcript exons
ENST00000372519 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001458006 | 45886491 | 45887145 |
| ENSE00001458008 | 45887536 | 45887622 |
Expression profiles
Bgee: expression breadth ubiquitous, 156 present calls, max score 83.60.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0049 / max 3.6087, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 187495 | 0.0049 | 3 |
Top tissues by expression
245 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 83.60 | gold quality |
| right testis | UBERON:0004534 | 83.23 | gold quality |
| testis | UBERON:0000473 | 80.28 | gold quality |
| right lobe of liver | UBERON:0001114 | 77.95 | gold quality |
| left ovary | UBERON:0002119 | 77.01 | gold quality |
| apex of heart | UBERON:0002098 | 76.00 | gold quality |
| right ovary | UBERON:0002118 | 75.96 | gold quality |
| muscle of leg | UBERON:0001383 | 75.08 | gold quality |
| buccal mucosa cell | CL:0002336 | 74.93 | silver quality |
| gastrocnemius | UBERON:0001388 | 74.61 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 73.97 | gold quality |
| right coronary artery | UBERON:0001625 | 73.52 | gold quality |
| left uterine tube | UBERON:0001303 | 73.48 | gold quality |
| body of uterus | UBERON:0009853 | 72.75 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 72.46 | gold quality |
| lower esophagus | UBERON:0013473 | 72.45 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 72.44 | gold quality |
| left coronary artery | UBERON:0001626 | 72.38 | gold quality |
| transverse colon | UBERON:0001157 | 72.26 | gold quality |
| endocervix | UBERON:0000458 | 72.10 | gold quality |
| stromal cell of endometrium | CL:0002255 | 72.09 | gold quality |
| popliteal artery | UBERON:0002250 | 71.93 | gold quality |
| tibial artery | UBERON:0007610 | 71.91 | gold quality |
| metanephros cortex | UBERON:0010533 | 71.74 | gold quality |
| mucosa of stomach | UBERON:0001199 | 71.66 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 71.55 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 71.50 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 71.43 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 71.37 | gold quality |
| cerebellar cortex | UBERON:0002129 | 71.26 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.63 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- study identified a novel gene, TSG23/Tsg23, which is developmentally & highly expressed in testis; data suggest that TSG23/Tsg23 is involved in human and mouse spermatogenesis (PMID:19240080)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spata25 | ENSMUSG00000017767 |
| rattus_norvegicus | Spata25 | ENSRNOG00000015744 |
Protein
Protein identifiers
Spermatogenesis-associated protein 25 — Q9BR10 (reviewed: Q9BR10)
Alternative names: Testis-specific gene 23 protein
All UniProt accessions (1): Q9BR10
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in spermatogenesis.
Subcellular location. Membrane.
Tissue specificity. Expressed predominantly in testis (at protein level). Expression is lower in patients with obstructive azoospermia than in fertile controls and is not detected in patients with non-obstructive azoospermia.
Similarity. Belongs to the SPATA25 family.
RefSeq proteins (1): NP_542175* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029192 | SPATA25 | Family |
Pfam: PF15218
UniProt features (5 total): region of interest 2, chain 1, transmembrane region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BR10-F1 | 57.29 | 0.02 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 21 (showing top):
GOBP_MALE_GAMETE_GENERATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, CP2_01, MARTENS_TRETINOIN_RESPONSE_DN, GSE13306_RA_VS_UNTREATED_TREG_DN, GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP, GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP, GOBP_SEXUAL_REPRODUCTION, GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN, GOBP_REPRODUCTIVE_PROCESS, GOBP_MULTICELLULAR_ORGANISMAL_REPRODUCTIVE_PROCESS, GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_UP, GENES_CORRELATED_WITH_IGF1R_DELETION, GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP, GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP
GO Biological Process (2): spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
418 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPATA25 | NEURL2 | Q9BR09 | 678 |
| SPATA25 | ZSWIM1 | Q9BR11 | 628 |
| SPATA25 | WFDC10B | Q8IUB3 | 575 |
| SPATA25 | SPATA46 | Q5T0L3 | 547 |
| SPATA25 | WFDC10A | Q9H1F0 | 541 |
| SPATA25 | SNX21 | Q969T3 | 532 |
| SPATA25 | ZNF335 | Q9H4Z2 | 506 |
| SPATA25 | PHIP | Q8WWQ0 | 504 |
| SPATA25 | ACOT8 | O14734 | 499 |
| SPATA25 | WFDC3 | Q8IUB2 | 498 |
| SPATA25 | IRAK1BP1 | Q5VVH5 | 485 |
| SPATA25 | TEX35 | Q5T0J7 | 464 |
| SPATA25 | SYS1 | Q8N2H4 | 461 |
| SPATA25 | SPATA3 | Q8NHX4 | 453 |
| SPATA25 | SPATA20 | Q8TB22 | 451 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TLE5 | SPATA25 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATA25 | TAF4 | psi-mi:“MI:0914”(association) | 0.530 |
| TLE5 | SPATA25 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (17): SPATA25 (Two-hybrid), TAF10 (Affinity Capture-MS), TAF9 (Affinity Capture-MS), TAF12 (Affinity Capture-MS), TAF11 (Affinity Capture-MS), TAF13 (Affinity Capture-MS), TAF3 (Affinity Capture-MS), TAF6 (Affinity Capture-MS), TAF1 (Affinity Capture-MS), TAF2 (Affinity Capture-MS), TAF4 (Affinity Capture-MS), TAF4B (Affinity Capture-MS), TAF5 (Affinity Capture-MS), TAF7 (Affinity Capture-MS), TAF9B (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GUT2, A2RUQ5, A8MU10, B1AH88, C0HM98, H3BQW9, P0C044, P0C092, P0CAT3, P0DPA3, P20977, P59052, P87743, Q06250, Q1R1V4, Q2M3A8, Q3SXR2, Q5SWW7, Q6Q795, Q6UXR6, Q6UXR8, Q6ZSR3, Q6ZSV7, Q6ZVH6, Q6ZWC4, Q71F78, Q86UQ8, Q8N2C9, Q8N2X6, Q8N616, Q8N814, Q8N8V8, Q8N9P6, Q8NBC4, Q8NBF4, Q96EZ4, Q96MC9, Q9BE57, Q9BR10, Q9BTD1
Diamond homologs: Q9BR10, Q9DA57
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
34 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 27 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
78 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:45887531:CTCAC:C | donor_loss | 0.9900 |
| 20:45887532:TCA:T | donor_loss | 0.9900 |
| 20:45887535:C:A | donor_loss | 0.9900 |
| 20:45887146:CTGC:C | acceptor_loss | 0.9500 |
| 20:45887554:G:GT | donor_gain | 0.9500 |
| 20:45886803:C:T | acceptor_gain | 0.9300 |
| 20:45887507:C:CA | donor_gain | 0.9300 |
| 20:45887534:A:AC | donor_gain | 0.9300 |
| 20:45887535:C:CC | donor_gain | 0.9300 |
| 20:45887141:CCCAC:C | acceptor_gain | 0.9100 |
| 20:45887142:CCACC:C | acceptor_gain | 0.9100 |
| 20:45887142:CCAC:C | acceptor_gain | 0.9000 |
| 20:45887143:CACC:C | acceptor_gain | 0.9000 |
| 20:45887146:C:CC | acceptor_gain | 0.9000 |
| 20:45887143:CAC:C | acceptor_gain | 0.8900 |
| 20:45887534:AC:A | donor_gain | 0.8500 |
| 20:45887535:CC:C | donor_gain | 0.8500 |
| 20:45886803:C:CT | acceptor_gain | 0.8300 |
| 20:45887534:A:C | donor_gain | 0.8200 |
| 20:45887531:CTCA:C | donor_gain | 0.8100 |
| 20:45887533:CA:C | donor_gain | 0.8000 |
| 20:45886794:G:T | acceptor_gain | 0.7900 |
| 20:45887156:A:T | acceptor_gain | 0.7900 |
| 20:45887148:G:C | acceptor_loss | 0.7800 |
| 20:45887552:A:AC | donor_gain | 0.7300 |
| 20:45887530:GCTCA:G | donor_gain | 0.7200 |
| 20:45886721:CATCA:C | acceptor_gain | 0.7100 |
| 20:45887144:AC:A | acceptor_gain | 0.7100 |
| 20:45887145:CC:C | acceptor_gain | 0.7100 |
| 20:45887529:CGCT:C | donor_gain | 0.7000 |
AlphaMissense
1453 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:45886710:A:G | I164T | 0.994 |
| 20:45886649:G:C | F184L | 0.992 |
| 20:45886649:G:T | F184L | 0.992 |
| 20:45886651:A:G | F184L | 0.992 |
| 20:45886717:C:G | A162P | 0.987 |
| 20:45886724:C:A | M159I | 0.987 |
| 20:45886724:C:G | M159I | 0.987 |
| 20:45886724:C:T | M159I | 0.987 |
| 20:45886710:A:C | I164S | 0.986 |
| 20:45886719:A:T | I161N | 0.986 |
| 20:45886728:G:T | A158D | 0.986 |
| 20:45886650:A:G | F184S | 0.985 |
| 20:45886716:G:T | A162D | 0.985 |
| 20:45886713:C:A | G163V | 0.983 |
| 20:45886719:A:C | I161S | 0.981 |
| 20:45886737:A:T | L155H | 0.981 |
| 20:45886740:A:G | I154T | 0.978 |
| 20:45886695:A:T | V169D | 0.977 |
| 20:45886650:A:C | F184C | 0.976 |
| 20:45886659:G:T | A181D | 0.976 |
| 20:45886731:A:T | L157H | 0.976 |
| 20:45886671:A:G | L177P | 0.975 |
| 20:45886731:A:G | L157P | 0.973 |
| 20:45886737:A:G | L155P | 0.972 |
| 20:45886721:C:A | M160I | 0.971 |
| 20:45886721:C:G | M160I | 0.971 |
| 20:45886721:C:T | M160I | 0.971 |
| 20:45886725:A:T | M159K | 0.971 |
| 20:45886725:A:C | M159R | 0.970 |
| 20:45886729:C:G | A158P | 0.967 |
dbSNP variants (sampled 300 via entrez): RS1000460046 (20:45889581 T>A), RS1000947010 (20:45889848 A>G), RS1001455876 (20:45890406 G>A,T), RS1003060294 (20:45889154 T>G), RS1003266283 (20:45887913 C>A), RS1003334266 (20:45889358 T>C), RS1003805541 (20:45891628 G>A,T), RS1005121712 (20:45889434 C>A,T), RS1005269664 (20:45889137 T>C), RS1005794566 (20:45892064 G>C), RS1005907488 (20:45890456 T>A), RS1006542703 (20:45890781 C>T), RS1006892424 (20:45891540 G>A,C), RS1007018466 (20:45891561 T>C,G), RS1007279364 (20:45886172 T>G)
Disease associations
OMIM: gene MIM:618936 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression | 2 |
| Particulate Matter | increases abundance, increases expression, decreases expression | 2 |
| decabromobiphenyl ether | affects expression | 1 |
| kojic acid | decreases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| abrine | increases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Fluorouracil | increases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Triclosan | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.